Free Trial
OTCMKTS:RZLTD

Rezolute (RZLTD) Stock Price, News & Analysis

$4.00 +0.04 (+1.01%)
As of 05/2/2025

About Rezolute Stock (OTCMKTS:RZLTD)

Key Stats

Today's Range
$3.86
$4.04
50-Day Range
$2.47
$4.43
52-Week Range
$16.00
$24.05
Volume
714,276 shs
Average Volume
4,788 shs
Market Capitalization
$33.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for rare and metabolic diseases in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also develops RZ402, a small molecule plasma kallikrein inhibitor, which is in preclinical stage for the treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

Receive RZLTD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rezolute and its competitors with MarketBeat's FREE daily newsletter.

RZLTD Stock News Headlines

Rezolute (RZLT) Earnings Dates & Reports
Xilio Development Inc (XLO)
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Systems Ltd.
See More Headlines

RZLTD Stock Analysis - Frequently Asked Questions

Rezolute's stock was trading at $4.96 at the start of the year. Since then, RZLTD stock has decreased by 19.4% and is now trading at $4.00.
View the best growth stocks for 2025 here
.

Shares of RZLTD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:RZLTD
CIK
N/A
Fax
N/A
Employees
23
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-20,330,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.24 per share
Price / Book
3.23

Miscellaneous

Free Float
N/A
Market Cap
$33.67 million
Optionable
Not Optionable
Beta
4.63
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:RZLTD) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners